Monday 18 December 2017
Contact US    |    Archive
PR
2 months ago

AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

NORTH CHICAGO, Ill., Oct. 11, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and develo

Read on the original site


IPL debut for DRS in 2018?

- cricketcountry

ELECTION-MAH-CIVIC

- Uniindia
Hashtags:   

AbbVie

 | 

Demonstrates

 | 

Leadership

 | 

HCV

 | 

with

 | 

New

 | 

MAVYRET™

 | 

glecaprevir

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries